Pekin Hardy Strauss’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.28M Sell
13,425
-1,833
-12% -$427K 0.34% 78
2025
Q4
$3.16M Buy
15,258
+673
+5% +$133K 0.29% 86
2025
Q3
$2.7M Sell
14,585
-1,284
-8% -$220K 0.27% 96
2025
Q2
$2.42M Sell
15,869
-5,199
-25% -$799K 0.28% 90
2025
Q1
$3.49M Sell
21,068
-2,596
-11% -$406K 0.42% 65
2024
Q4
$3.42M Sell
23,664
-2,589
-10% -$401K 0.43% 62
2024
Q3
$4.25M Sell
26,253
-528
-2% -$84.1K 0.54% 58
2024
Q2
$3.91M Sell
26,781
-452
-2% -$67.2K 0.54% 57
2024
Q1
$4.31M Sell
27,233
-489
-2% -$77.8K 0.59% 49
2023
Q4
$4.35M Sell
27,722
-1,949
-7% -$299K 0.61% 46
2023
Q3
$4.62M Sell
29,671
-692
-2% -$114K 0.73% 39
2023
Q2
$5.03M Sell
30,363
-474
-2% -$76.5K 0.55% 37
2023
Q1
$4.78M Sell
30,837
-340
-1% -$54.9K 0.64% 41
2022
Q4
$5.51M Sell
31,177
-580
-2% -$100K 0.76% 35
2022
Q3
$5.19M Sell
31,757
-341
-1% -$57.7K 0.83% 32
2022
Q2
$5.7M Sell
32,098
-149
-0.5% -$26.5K 0.8% 30
2022
Q1
$5.71M Sell
32,247
-115
-0.4% -$19.6K 0.71% 32
2021
Q4
$5.54M Sell
32,362
-349
-1% -$57.1K 0.75% 33
2021
Q3
$5.28M Sell
32,711
-49
-0.1% -$8.36K 0.75% 29
2021
Q2
$5.4M Sell
32,760
-3,907
-11% -$647K 0.75% 31
2021
Q1
$6.03M Sell
36,667
-841
-2% -$136K 0.95% 29
2020
Q4
$5.9M Buy
37,508
+1,027
+3% +$152K 1.03% 26
2020
Q3
$5.43M Buy
36,481
+2,325
+7% +$344K 1.11% 22
2020
Q2
$4.8M Buy
34,156
+508
+2% +$74K 1.06% 27
2020
Q1
$4.41M Sell
33,648
-946
-3% -$134K 0.99% 26
2019
Q4
$5.05M Sell
34,594
-1,789
-5% -$243K 0.83% 36
2019
Q3
$4.71M Sell
36,383
-760
-2% -$100K 0.92% 33
2019
Q2
$5.17M Buy
37,143
+100
+0.3% +$13.8K 1.02% 30
2019
Q1
$5.18M Sell
37,043
-360
-1% -$48.2K 0.41% 30
2018
Q4
$4.83M Sell
37,403
-120
-0.3% -$16.7K 0.84% 30
2018
Q3
$5.18M Sell
37,523
-657
-2% -$87.3K 0.9% 30
2018
Q2
$4.63M Sell
38,180
-2,664
-7% -$332K 0.88% 34
2018
Q1
$5.23M Sell
40,844
-2,408
-6% -$325K 0.95% 32
2017
Q4
$6.04M Buy
43,252
+603
+1% +$84K 1.1% 29
2017
Q3
$5.54M Sell
42,649
-385
-0.9% -$51K 1.04% 29
2017
Q2
$5.69M Sell
43,034
-1,534
-3% -$196K 0.9% 26
2017
Q1
$5.55M Sell
44,568
-1,156
-3% -$138K 1.09% 26
2016
Q4
$5.27M Buy
45,724
+476
+1% +$55K 0.47% 23
2016
Q3
$5.34M Sell
45,248
-1,371
-3% -$166K 0.91% 24
2016
Q2
$5.66M Sell
46,619
-2,569
-5% -$292K 1.24% 22
2016
Q1
$5.32M Buy
49,188
+30
+0.1% +$3.11K 1.24% 22
2015
Q4
$5.05M Buy
49,158
+560
+1% +$56.3K 1.15% 26
2015
Q3
$4.54M Buy
48,598
+1,510
+3% +$146K 1.04% 28
2015
Q2
$4.59M Buy
47,088
+500
+1% +$50.1K 0.89% 30
2015
Q1
$4.69M Sell
46,588
-4,525
-9% -$460K 0.87% 30
2014
Q4
$5.34M Sell
51,113
-1,010
-2% -$106K 0.79% 27
2014
Q3
$5.56M Sell
52,123
-100
-0.2% -$10.4K 0.94% 27
2014
Q2
$5.46M Sell
52,223
-200
-0.4% -$20.2K 0.86% 27
2014
Q1
$5.15M Buy
52,423
+50
+0.1% +$4.64K 0.84% 26
2013
Q4
$4.8M Sell
52,373
-1,801
-3% -$166K 0.74% 30
2013
Q3
$4.7M Sell
54,174
-11,064
-17% -$993K 0.74% 28
2013
Q2
$5.6M Buy
+65,238
New +$5.54M 0.95% 24

Other funds holding JNJ

Pekin Hardy Strauss's JNJ Position: Q1 2026 in Review

Pekin Hardy Strauss reduced its Johnson & Johnson (JNJ) stake by 12% in Q1 2026, selling an estimated $427K and leaving 13,425 shares worth $3.28M. The position accounts for 0.34% of the portfolio, ranked #78.

Pekin Hardy Strauss first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.04M in Q4 2017. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Pekin Hardy Strauss held 13,425 shares of Johnson & Johnson worth $3.28M as of Q1 2026.
  • Pekin Hardy Strauss sold 1,833 Johnson & Johnson shares in Q1 2026, an estimated $427K.
  • Johnson & Johnson made up 0.34% of Pekin Hardy Strauss's portfolio in Q1 2026, its #78 holding.
  • Pekin Hardy Strauss first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Pekin Hardy Strauss's Johnson & Johnson position peaked at $6.04M in Q4 2017.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Pekin Hardy Strauss's 13F filing for Q1 2026, filed 7 May 2026.